Literature DB >> 19428268

Endocannabinoids and immune regulation.

Rupal Pandey1, Khalida Mousawy, Mitzi Nagarkatti, Prakash Nagarkatti.   

Abstract

Cannabinoid pharmacology has made important advances in recent years after the discovery of the cannabinoid receptors. These discoveries have added to our understanding of exogenous and endogenous cannabinoid signaling along with exploring the various pathways of their biosynthesis, molecular structure, inactivation, and anatomical distribution of their receptors throughout the body. The endocannabinoid system is involved in immunoregulation and neuroprotection. In this article, we have reviewed the possible mechanisms of the regulation of the immune response by endocannabinoids which include modulation of immune response in different cell types, effect on cytokine network, induction of apoptosis in immune cells and downregulation of innate and adaptive immune response. Studies from our laboratory have suggested that administration of endocannabinoids or use of inhibitors of enzymes that breakdown the endocannabinoids, leads to immunosuppression and recovery from immune-mediated injury to organs such as the liver. Thus, manipulation of endocannabinoids in vivo may constitute a novel treatment modality against inflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428268      PMCID: PMC3044336          DOI: 10.1016/j.phrs.2009.03.019

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  99 in total

1.  Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells.

Authors:  E V Berdyshev; E Boichot; N Germain; N Allain; J P Anger; V Lagente
Journal:  Eur J Pharmacol       Date:  1997-07-09       Impact factor: 4.432

2.  Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides.

Authors:  B F Cravatt; D K Giang; S P Mayfield; D L Boger; R A Lerner; N B Gilula
Journal:  Nature       Date:  1996-11-07       Impact factor: 49.962

3.  Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes.

Authors:  G B Stefano; Y Liu; M S Goligorsky
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

4.  The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.

Authors:  J M Derocq; M Bouaboula; J Marchand; M Rinaldi-Carmona; M Ségui; P Casellas
Journal:  FEBS Lett       Date:  1998-04-03       Impact factor: 4.124

5.  Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes.

Authors:  T Bisogno; S Maurelli; D Melck; L De Petrocellis; V Di Marzo
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

6.  Inhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and kappaB elements by cannabinol, a minimally CNS-active cannabinoid.

Authors:  A C Herring; W S Koh; N E Kaminski
Journal:  Biochem Pharmacol       Date:  1998-04-01       Impact factor: 5.858

7.  Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells.

Authors:  P Valk; S Verbakel; Y Vankan; S Hol; S Mancham; R Ploemacher; A Mayen; B Löwenberg; R Delwel
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

8.  Functional role of high-affinity anandamide transport, as revealed by selective inhibition.

Authors:  M Beltramo; N Stella; A Calignano; S Y Lin; A Makriyannis; D Piomelli
Journal:  Science       Date:  1997-08-22       Impact factor: 47.728

9.  Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system.

Authors:  V K Pestonjamasp; S H Burstein
Journal:  Biochim Biophys Acta       Date:  1998-11-02

10.  Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension.

Authors:  K Varga; J A Wagner; D T Bridgen; G Kunos
Journal:  FASEB J       Date:  1998-08       Impact factor: 5.191

View more
  62 in total

1.  Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1.

Authors:  Austin R Jackson; Venkatesh L Hegde; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Leukoc Biol       Date:  2013-12-06       Impact factor: 4.962

Review 2.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

Review 3.  Endocannabinoid signalling in innate and adaptive immunity.

Authors:  Valerio Chiurchiù; Luca Battistini; Mauro Maccarrone
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

Review 4.  Polarity scaffolds signaling in epithelial cell permeability.

Authors:  Lauren F O'Leary; Andrea M Tomko; Denis J Dupré
Journal:  Inflamm Res       Date:  2021-03-15       Impact factor: 4.575

5.  Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury.

Authors:  Y Yang; H Yang; Z Wang; K Varadaraj; S S Kumari; S Mergler; Y Okada; S Saika; P J Kingsley; L J Marnett; P S Reinach
Journal:  Cell Signal       Date:  2012-11-08       Impact factor: 4.315

Review 6.  Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls.

Authors:  Matthew W Buczynski; Loren H Parsons
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 7.  Physical activity and the endocannabinoid system: an overview.

Authors:  Mirko Tantimonaco; Roberta Ceci; Stefania Sabatini; Maria Valeria Catani; Antonello Rossi; Valeria Gasperi; Mauro Maccarrone
Journal:  Cell Mol Life Sci       Date:  2014-02-14       Impact factor: 9.261

8.  Impact of HIV and a history of marijuana dependence on procedural learning among individuals with a history of substance dependence.

Authors:  Raul Gonzalez; Randi M Schuster; Jasmin Vassileva; Eileen M Martin
Journal:  J Clin Exp Neuropsychol       Date:  2011-06-24       Impact factor: 2.475

9.  N-Octanoyl dopamine transiently inhibits T cell proliferation via G1 cell-cycle arrest and inhibition of redox-dependent transcription factors.

Authors:  Johannes Wedel; Maximillia C Hottenrott; Eleni Stamellou; Annette Breedijk; Charalambos Tsagogiorgas; Jan-Luuk Hillebrands; Benito A Yard
Journal:  J Leukoc Biol       Date:  2014-06-13       Impact factor: 4.962

10.  Inhibitory effect of N-Acyl dopamines on IgE-mediated allergic response in RBL-2H3 cells.

Authors:  Jae-Myung Yoo; Eun Seok Park; Mee Ree Kim; Dai-Eun Sok
Journal:  Lipids       Date:  2013-02-02       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.